Dr. Madhav Danthala-Medical Oncologist

Dr. Madhav Danthala, Medical Oncologist

MBBS, MD, DM (Medical Oncology)

Fellowship in Leukemia and Bone Marrow Transplantation

Specializations

  • Medical Oncologist

  • Bonemarrow Transplant

  • Haemato Oncologist

Qualifications

  • MBBS - PES Institute of Medical Sciences and Research - 2009 - Kuppam Verified
  • MD - Internal Medicine - Sri Devaraj Urs Medical College - 2013 - Kolar Verified
  • DM - Medical Oncology - Nizam’s Institute of Medical Sciences - 2017 - Hyderabad Verified
  • Operational Research Certificate Course - WHO, SORT IT, The Union - 2019 Verified
  • Fellowship in Leukemia and Bone Marrow Transplantation - Vancouver General Hospital, University of British Columbia - 2020 - Canada Verified

Experiences

  • Resident Doctor - Department of Medical Oncology HCG Cancer Center - Bengaluru - Jun 2013 - Nov 2013
  • Consultant Hemato-Oncologist and BMT Physician Manipal Hospitals - Vijayawada - Sep 2017 - Jan 2022
  • Consultant Hemato-Oncologist and Bone Marrow Transplant Physician Yashoda Hospitals - Somajiguda - Feb 2022 - Aug Currently Working

Registrations

  • 66157 Andhra Pradesh Medical Council 2010 Verified

Awards and Recognitions

  • University Topper (SDUAHER) Internal Medicine - 2013
  • Best Poster Presentation Award at ICON - 2016
  • ISMPO-Torrent Young Scholar Award - 2017
  • 1st Rank, DM Medical Oncology Entrance Examination, Nizam’s Institute of Medical Sciences
  • Performed the First Matched Sibling Donor and Haploidentical Stem Cell Transplant in Andhra Pradesh
  • Instrumental in Successfully Setting up the Allogeneic Stem Cell Transplant Program at Manipal Hospitals, Vijayawada and performed more than 50 Stem Cell Transplants, the Highest in the State

Memberships

  • Medical Oncology Forum (MOF)
  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • American Society of Clinical Oncology (ASCO)

Paper Presentations

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE Therapy in Patients with Neuroendocrine Tumours: 5 Years Experience from a Tertiary Cancer Care Centre in India. European Journal of Nuclear Medicine and Molecular Imaging. 2014 Jul;41(7):1319-26
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic Imatinib in Chronic Myeloid Leukemia: Survival of the Cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62
  • Danthala M, Golamari KR, Seshachalam A, Mikkilineni A, Chappidi S, Mekala MB, Elangovan V, Chinnakali P. Walking a Tightrope: Dosage Modifications and Treatment Outcomes of All Trans-Retinoic Acid, Arsenic Trioxide, and Daunorubicin for HighRisk Acute Promyelocytic Leukemia. JCO Global Oncology. 2020 Nov;6:1749-56
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: 8 Years Experience from a Tertiary Care Center in India. South Asian Journal of Cancer. 2016 Oct;5(04):176-8
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value—A Multicenter Study from South India. Clinical Lymphoma Myeloma and Leukemia. 2020 May 1;20(5):e205-11
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of Global Oncology. 2019 Dec;5:1-3
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long Term Survival and Late Side Effects of Paediatric Hodgkin Lymphoma Patients: A Study from a Tertiary Care Centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and Breast Cancer: Association of Serum Adiponectin, Leptin, and Adiponectin–Leptin Ratio as Risk Biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul;39(03):292-6
  • Danthala M, Lakshmaiah V. Correlative Study of Serum Cystatin C Levels with Severity of Acute Ischemic Stroke. J Clin Biomed Sci. 2013;3(4):188-92
  • Naveen L, Santoshi M, Madhav D, Sri Rama AG, Mahesh V. A Study of the Association of Insulin Resistance and Cardiometabolic Risk Factors in an Adult Population with Type 2 Diabetes Mellitus, Inter. J. Appl. Med. Sci. 2014;4:168-72
  • Proffered Paper: Additional Chromosomal Abnormalities in Chronic Myeloid Leukemia: Lest We Forget. Presented at ESMO (European Society of Medical Oncology) Asia 2016, Singapore
  • ?Generic Lmatinib in Chronic Myeloid Leukemia: Survival of the Cheapest. Presented at ASH 2016 (Annual American Society of Hematology Conference), San Diego. Shortlisted for Best of ASH
  • Microalbuminuric Anemia: A Study of the Relationship Between Hemoglobin Levels and Albuminuria In Diabetes. KAPICON - 2012
  • Obesity and Breast Cancer: Association of Serum Adiponectin, Leptin and Adiponectin-Leptin Ratio as Risk Biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology Conference at Delhi - 2016
  • Renal Reversibility in Multiple Myeloma: A Race Against the Clock! Presented at Myeloma: State of the Art, PGI Chandigarh - 2016
  • Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: 8 years’ Experience from a Tertiary Care center in India. Presented at Annual Asian Clinical Oncology Society Conference , Delhi - 2016
  • Frontline Imatinib in Chronic Myeloid Leukemia: A Jewel in the Crown, Presented at Hematocon , Jaipur - 2016
  • Pediatric Chronic Myeloid Leukemia: Wise to Generalize? Presented at ISMPOCON , Delhi - 2016
  • Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/ M1 with prior Myelodysplastic Syndrome Transformed from Fanconi Anemia – A Case Report. HEMATOCON - 2015
  • Phenytoin Induced Cerebellar Ataxia and Orofacial Dyskinesia in a Rare Case of Disseminated Cysticercosis. APICON - 2013

Report an error

Dr. Madhav Danthala Practice Locations

Yashoda Hospitals - Somajiguda - Hyderabad

Yashoda Hospitals

location-icon

Rajbhavan Road

Matha Nagar

Somajiguda, Hyderabad

Get directions

time-icon

OP Timings

Mon - Sat

09:00 am - 05:00 pm
...

Fee : 850

Write a review for Dr. Madhav Danthala

Which clinic or hospital you visited

empty

I Recommend this Doctor for

How was your experience

Write your experience aboutDr. Madhav Danthala

Ask a
Question!

Right Doctor at the Right time, can save you time, money and health ! Find them on skedoc

Popular Searches

Top doctors in HyderabadTop hospitals in Hyderabad
skedoc | Right Doctor Right Advice

skedoc brings you healthcare that is relevant to your specific health needs. We make finding the Right Doctor and the Right Advice extremely easy.

Quick Links

About UsContact UsAnswers by SpecialistsArticles on Health Health QuizSite MapPrivacy PolicyTerms Of Use

Locations

Andhra Pradesh

Guntur
Kurnool
Tirupathi
Vijayawada
Visakhapatnam

Madhya Pradesh

Bhopal
Indore

Telangana

Hyderabad
Karimnagar
Khammam
Medak
Nizamabad
Warangal

West Bengal

Kolkata

Quick Contact

Connect with us

skedoc | Right Doctor Right Advice

skedoc brings you healthcare that is relevant to your specific health needs. We make finding the Right Doctor and the Right Advice extremely easy.

  • Home
  • Search
  • Doctors
  • Hospitals